Inari Medical, now part of Stryker, has introduced the InThrill Thrombectomy System, a novel device aimed at addressing arteriovenous access and small vessel thrombus cases.
The system is specifically designed for small vessel and arteriovenous access thrombectomy, offering rapid and comprehensive luminal clot removal.
The second-generation InThrill Thrombectomy System features an 8 French over-the-wire configuration, comprising the InThrill thrombectomy catheter and sheath.
Built on a familiar platform, the system is optimised for arteriovenous access and small vessel thrombectomy.
The system features enhanced efficiency and clot removal capabilities, including an increased radial force for better luminal wall apposition.
It also comes with an offset single open mouth for optimised clot capture, internal struts for even clot distribution, and a redesigned backend for improved ergonomics.
Inari Division president Tim Lanier said: “The launch of the next-generation InThrill Thrombectomy System reflects our deep commitment to solving real-world challenges in vascular care.
“This latest innovation delivers new tools and enriches our work with physicians in the vascular space.”
In May this year, Dr Joshua Pinter and Dr Anish Ghodadra from the UPMC healthcare system conducted the first commercial procedure using the InThrill Thrombectomy System.
The device is indicated for the non-surgical removal of thrombi and emboli from blood vessels, including arteriovenous fistulae and grafts for dialysis access, and synthetic grafts.
It also supports the injection, infusion, and aspiration of contrast media and other fluids into or from a blood vessel or graft.
The InThrill Sheath serves as a conduit for inserting endovascular devices into the peripheral vasculature, aiming to reduce blood loss during such procedures.
However, the InThrill Thrombectomy System is not intended for deep vein thrombosis treatment.
Dr Pinter said: “The next generation of InThrill has made our thrombectomies more effective and consistent than ever.
Dr Ghodadra said: “Inari’s dedication to building a small vessel tool has changed our paradigm of treatment for AV access thrombectomy.”
